Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015

Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta Felquer, April W Armstrong, Wilson Bautista Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli, Luis R Espinoza, Oliver FitzGerald, Dafna D Gladman, Alice Gottlieb, Philip S Helliwell, M Elaine Husni, Thorvardur J Love, Ennio Lubrano, Neil McHugh, Peter Nash & 10 others Alexis Ogdie, Ana-Maria Orbai, Andrew Parkinson, Denis O'Sullivan, Cheryl F Rosen, Sergio Schwartzman, Evan L Siegel, Sergio Toloza, William Tuong, Christopher T Ritchlin

Research output: Contribution to journalArticle

  • 122 Citations

Abstract

OBJECTIVE: Update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA).

METHODS: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA patients based on consensus at face-to-face meetings and via online surveys. We published literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease), and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, with an online questionnaire.

RESULTS: Six overarching principles had at least 80% agreement among both health care professionals (HCPs; n=135) and patient research partners (PRPs; n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease, and comorbidities in the setting of PsA, using the GRADE process. Over 80% agreement was reached for approval of the individual recommendations and the overall schema.

CONCLUSION: Herein, we present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other HCPs, and PRPs). Further updates are anticipated as the therapeutic landscape in PsA evolves.

LanguageEnglish
Pages1060-1071
JournalArthritis & Rheumatology
Volume68
Issue number5
Early online date23 Mar 2016
DOIs
StatusPublished - May 2016

Fingerprint

Psoriatic Arthritis
Psoriasis
Research
Nail Diseases
Therapeutics
Spondylitis
Comorbidity
Skin Diseases
Arthritis

Cite this

Coates, L. C., Kavanaugh, A., Mease, P. J., Soriano, E. R., Laura Acosta Felquer, M., Armstrong, A. W., ... Ritchlin, C. T. (2016). Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015. Arthritis & Rheumatology, 68(5), 1060-1071. DOI: 10.1002/art.39573

Group for research and assessment of psoriasis and psoriatic arthritis : treatment recommendations for psoriatic arthritis 2015. / Coates, Laura C; Kavanaugh, Arthur; Mease, Philip J; Soriano, Enrique R; Laura Acosta Felquer, Maria; Armstrong, April W; Bautista Molano, Wilson; Boehncke, Wolf-Henning; Campbell, Willemina; Cauli, Alberto; Espinoza, Luis R; FitzGerald, Oliver; Gladman, Dafna D; Gottlieb, Alice; Helliwell, Philip S; Elaine Husni, M; Love, Thorvardur J; Lubrano, Ennio; McHugh, Neil; Nash, Peter; Ogdie, Alexis; Orbai, Ana-Maria; Parkinson, Andrew; O'Sullivan, Denis; Rosen, Cheryl F; Schwartzman, Sergio; Siegel, Evan L; Toloza, Sergio; Tuong, William; Ritchlin, Christopher T.

In: Arthritis & Rheumatology, Vol. 68, No. 5, 05.2016, p. 1060-1071.

Research output: Contribution to journalArticle

Coates, LC, Kavanaugh, A, Mease, PJ, Soriano, ER, Laura Acosta Felquer, M, Armstrong, AW, Bautista Molano, W, Boehncke, W-H, Campbell, W, Cauli, A, Espinoza, LR, FitzGerald, O, Gladman, DD, Gottlieb, A, Helliwell, PS, Elaine Husni, M, Love, TJ, Lubrano, E, McHugh, N, Nash, P, Ogdie, A, Orbai, A-M, Parkinson, A, O'Sullivan, D, Rosen, CF, Schwartzman, S, Siegel, EL, Toloza, S, Tuong, W & Ritchlin, CT 2016, 'Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015' Arthritis & Rheumatology, vol 68, no. 5, pp. 1060-1071. DOI: 10.1002/art.39573
Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta Felquer M, Armstrong AW et al. Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015. Arthritis & Rheumatology. 2016 May;68(5):1060-1071. Available from, DOI: 10.1002/art.39573
Coates, Laura C ; Kavanaugh, Arthur ; Mease, Philip J ; Soriano, Enrique R ; Laura Acosta Felquer, Maria ; Armstrong, April W ; Bautista Molano, Wilson ; Boehncke, Wolf-Henning ; Campbell, Willemina ; Cauli, Alberto ; Espinoza, Luis R ; FitzGerald, Oliver ; Gladman, Dafna D ; Gottlieb, Alice ; Helliwell, Philip S ; Elaine Husni, M ; Love, Thorvardur J ; Lubrano, Ennio ; McHugh, Neil ; Nash, Peter ; Ogdie, Alexis ; Orbai, Ana-Maria ; Parkinson, Andrew ; O'Sullivan, Denis ; Rosen, Cheryl F ; Schwartzman, Sergio ; Siegel, Evan L ; Toloza, Sergio ; Tuong, William ; Ritchlin, Christopher T. / Group for research and assessment of psoriasis and psoriatic arthritis : treatment recommendations for psoriatic arthritis 2015. In: Arthritis & Rheumatology. 2016 ; Vol. 68, No. 5. pp. 1060-1071
@article{4688b1e833694e39921566a3f6060ddf,
title = "Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis 2015",
abstract = "OBJECTIVE: Update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA).METHODS: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA patients based on consensus at face-to-face meetings and via online surveys. We published literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease), and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, with an online questionnaire.RESULTS: Six overarching principles had at least 80{\%} agreement among both health care professionals (HCPs; n=135) and patient research partners (PRPs; n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease, and comorbidities in the setting of PsA, using the GRADE process. Over 80{\%} agreement was reached for approval of the individual recommendations and the overall schema.CONCLUSION: Herein, we present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other HCPs, and PRPs). Further updates are anticipated as the therapeutic landscape in PsA evolves.",
author = "Coates, {Laura C} and Arthur Kavanaugh and Mease, {Philip J} and Soriano, {Enrique R} and {Laura Acosta Felquer}, Maria and Armstrong, {April W} and {Bautista Molano}, Wilson and Wolf-Henning Boehncke and Willemina Campbell and Alberto Cauli and Espinoza, {Luis R} and Oliver FitzGerald and Gladman, {Dafna D} and Alice Gottlieb and Helliwell, {Philip S} and {Elaine Husni}, M and Love, {Thorvardur J} and Ennio Lubrano and Neil McHugh and Peter Nash and Alexis Ogdie and Ana-Maria Orbai and Andrew Parkinson and Denis O'Sullivan and Rosen, {Cheryl F} and Sergio Schwartzman and Siegel, {Evan L} and Sergio Toloza and William Tuong and Ritchlin, {Christopher T}",
year = "2016",
month = "5",
doi = "10.1002/art.39573",
language = "English",
volume = "68",
pages = "1060--1071",
journal = "Arthritis & Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Group for research and assessment of psoriasis and psoriatic arthritis

T2 - Arthritis & Rheumatology

AU - Coates,Laura C

AU - Kavanaugh,Arthur

AU - Mease,Philip J

AU - Soriano,Enrique R

AU - Laura Acosta Felquer,Maria

AU - Armstrong,April W

AU - Bautista Molano,Wilson

AU - Boehncke,Wolf-Henning

AU - Campbell,Willemina

AU - Cauli,Alberto

AU - Espinoza,Luis R

AU - FitzGerald,Oliver

AU - Gladman,Dafna D

AU - Gottlieb,Alice

AU - Helliwell,Philip S

AU - Elaine Husni,M

AU - Love,Thorvardur J

AU - Lubrano,Ennio

AU - McHugh,Neil

AU - Nash,Peter

AU - Ogdie,Alexis

AU - Orbai,Ana-Maria

AU - Parkinson,Andrew

AU - O'Sullivan,Denis

AU - Rosen,Cheryl F

AU - Schwartzman,Sergio

AU - Siegel,Evan L

AU - Toloza,Sergio

AU - Tuong,William

AU - Ritchlin,Christopher T

PY - 2016/5

Y1 - 2016/5

N2 - OBJECTIVE: Update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA).METHODS: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA patients based on consensus at face-to-face meetings and via online surveys. We published literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease), and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, with an online questionnaire.RESULTS: Six overarching principles had at least 80% agreement among both health care professionals (HCPs; n=135) and patient research partners (PRPs; n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease, and comorbidities in the setting of PsA, using the GRADE process. Over 80% agreement was reached for approval of the individual recommendations and the overall schema.CONCLUSION: Herein, we present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other HCPs, and PRPs). Further updates are anticipated as the therapeutic landscape in PsA evolves.

AB - OBJECTIVE: Update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA).METHODS: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA patients based on consensus at face-to-face meetings and via online surveys. We published literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease), and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, with an online questionnaire.RESULTS: Six overarching principles had at least 80% agreement among both health care professionals (HCPs; n=135) and patient research partners (PRPs; n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin, and nail disease, and comorbidities in the setting of PsA, using the GRADE process. Over 80% agreement was reached for approval of the individual recommendations and the overall schema.CONCLUSION: Herein, we present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other HCPs, and PRPs). Further updates are anticipated as the therapeutic landscape in PsA evolves.

UR - http://dx.doi.org/10.1002/art.39573

U2 - 10.1002/art.39573

DO - 10.1002/art.39573

M3 - Article

VL - 68

SP - 1060

EP - 1071

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5191

IS - 5

ER -